tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Similar Stocks

Compare
167 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$1.86
$140.51M
-17.33%
0 Buy
1 Hold
0 Sell
Hold
Cue Biopharma
$0.72
$43.27M
-59.20%
2 Buy
0 Hold
0 Sell
Moderate Buy
Exicure
$11.30
$72.65M
293.88%
Annovis Bio
$1.28
$25.14M
-89.34%
1 Buy
1 Hold
0 Sell
Moderate Buy
Athira Pharma
$0.24
$9.16M
-90.98%
0 Buy
3 Hold
0 Sell
Hold
Context Therapeutics
$0.68
$60.10M
-55.33%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IKT
Inhibikase Therapeutics
1.86
-0.33
-15.07%
CUE
Cue Biopharma
0.72
-1.03
-58.86%
XCUR
Exicure
11.58
8.68
299.31%
ANVS
Annovis Bio
1.30
-10.33
-88.82%
ATHA
Athira Pharma
0.24
-2.20
-90.16%
CNTX
Context Therapeutics
0.68
-0.81
-54.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis